Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bloomage Biotech is a China-based biotechnology and biomaterials company best known as a global leader in hyaluronic acid industrialization. The company develops and manufactures sodium hyaluronate and other bioactive ingredients for pharmaceutical, medical device, cosmetic, and nutrition applications, with more than 200 product specifications across its portfolio. Its core capabilities center on microbial fermentation, enzymatic degradation, and cross-linking technologies, which support both raw materials and formulated end-product businesses. Bloomage has expanded beyond hyaluronic acid into adjacent bioactive substances including collagen, functional sugars, amino acids, polypeptides, and other health and beauty ingredients. For a biotech analyst, the company is best understood as a commercial-stage health-related ingredients and biomaterials platform company rather than a traditional drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bloomega BioTechnology.